| |
| |
|
| Insider
Information: |
Makhzoumi Mohamad |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
20 |
|
| Direct
Shares |
16,083 |
|
|
Indirect Shares
|
68,130,184 |
|
|
| Direct
Value |
$176,615 |
|
|
|
Indirect Value
|
$238,820,452 |
|
|
| Total
Shares |
68,146,267 |
|
|
| Total
Value |
$238,997,066 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
2
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
2
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
 23.7%
|
 -32.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
2022-10-19 |
559 |
2022-10-19 |
354 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2023-06-13 |
11,348 |
Premium* |
|
|
Ardelyx Inc |
ARDX |
10% Owner |
2019-12-09 |
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
|
Eargo, Inc. |
EAR |
10% Owner |
2021-05-25 |
0 |
2021-05-24 |
0 |
Premium* |
|
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
2021-06-08 |
1,273 |
2021-06-08 |
806 |
Premium* |
|
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2023-07-17 |
24,471,264 |
Premium* |
|
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
|
Bright Health Group Inc. |
BHG |
|
2024-05-12 |
5,943 |
2024-05-12 |
2,280,552 |
Premium* |
|
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
|
Robinhood Markets, Inc. |
HOOD |
Director |
2022-05-02 |
6,371 |
2022-05-03 |
0 |
Premium* |
|
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-11-16 |
1,654 |
2022-11-16 |
1,047 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-12-20 |
283 |
2022-12-21 |
0 |
Premium* |
|
|
Korro Bio |
KRRO |
|
|
0 |
2024-04-22 |
1,090,793 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
97 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRRO |
Korro Bio |
|
– – • |
2024-04-22 |
4 |
B |
$56.00 |
$999,992 |
I/I |
17,857 |
1,090,793 |
0.01 |
- |
|
| BHG |
Bright Health Group Inc. |
|
– • • |
2024-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,755 |
5,943 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2017-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,989,010 |
|
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-06-27 |
4 |
B |
$2.15 |
$11,384 |
I/I |
5,295 |
17,596,592 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-06-28 |
4 |
B |
$2.10 |
$392,692 |
I/I |
187,130 |
17,783,722 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-07-18 |
4 |
B |
$1.95 |
$390,580 |
I/I |
200,000 |
17,983,722 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-07-19 |
4 |
B |
$2.00 |
$101,165 |
I/I |
50,600 |
18,034,322 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-08-21 |
4 |
B |
$2.26 |
$1,499,998 |
I/I |
663,716 |
18,698,038 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-15 |
4 |
B |
$1.86 |
$631,958 |
I/I |
340,000 |
19,038,038 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-16 |
4 |
B |
$1.86 |
$649,355 |
I/I |
350,000 |
19,388,038 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-19 |
4 |
B |
$1.88 |
$956,658 |
I/I |
510,000 |
19,898,038 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-20 |
4 |
B |
$1.98 |
$336,107 |
I/I |
170,000 |
20,068,038 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-28 |
4 |
B |
$1.99 |
$48,824 |
I/I |
24,500 |
20,092,538 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-11-30 |
4 |
B |
$1.98 |
$142,067 |
I/I |
71,900 |
20,164,438 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-06 |
4 |
B |
$1.99 |
$54,414 |
I/I |
27,300 |
20,191,738 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-07 |
4 |
B |
$1.98 |
$232,362 |
I/I |
117,100 |
20,308,838 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-10 |
4 |
B |
$1.98 |
$51,576 |
I/I |
26,000 |
20,334,838 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-11 |
4 |
B |
$1.98 |
$121,084 |
I/I |
61,200 |
20,396,038 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-20 |
4 |
B |
$1.63 |
$326,060 |
I/I |
200,000 |
20,596,038 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2018-12-21 |
4 |
B |
$1.49 |
$448,380 |
I/I |
300,000 |
20,896,038 |
1.5 |
- |
|
| GNCA |
Genocea Biosciences, Inc. |
10% Owner |
– – • |
2019-02-14 |
4 |
B |
$0.47 |
$4,688,619 |
I/I |
9,948,269 |
34,948,269 |
1.5 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
– – • |
2019-04-08 |
4 |
B |
$1.14 |
$4,956,523 |
I/I |
4,347,827 |
25,243,865 |
1.5 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
10% Owner |
– – • |
2019-05-07 |
4 |
B |
$1.08 |
$1,227,640 |
I/I |
1,136,704 |
2,052,454 |
1.5 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
I/I |
1,938,562 |
1,938,562 |
0 |
- |
|
| TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
– – • |
2019-05-09 |
4 |
B |
$10.00 |
$25,000,000 |
I/I |
2,500,000 |
4,438,562 |
1.5 |
- |
|
97 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
